Aortic Stenosis Treated With Tavi Clinical Trials
2 recruiting trials for Aortic Stenosis Treated With Tavi. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Aortic Stenosis Treated With Tavi clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by EnCompass Technologies, Inc. (1), University Hospital, Montpellier (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is F2 Filter and Delivery System (device, 1 trial), followed by Transcatheter Aortic Valve Replacement (TAVR), Pacemaker and defibrillator.
Track Aortic Stenosis Treated With Tavi trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
The objective of this study is to compare the safety and effectiveness of the F2 Cerebral Protection System (CPS) to a standard of care control group in patients undergoing...
One Year Pacing Dependency After TAVR
Pace maker implantation after the procedure of TAVR can be estimated at 15% of patients. However, some studies have shown that the conduction disturbances after TAVR could resolve...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Aortic Stenosis Treated With Tavi, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Aortic Stenosis Treated With Tavi, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Aortic Stenosis Treated With Tavi, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.